Clear Harbor Asset Management’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-74,843
Closed -$546K 439
2022
Q4
$546K Sell
74,843
-13,573
-15% -$95.7K 0.07% 198
2022
Q3
$612K Hold
88,416
0.09% 167
2022
Q2
$618K Buy
88,416
+1,325
+2% +$10.3K 0.08% 189
2022
Q1
$720K Buy
87,091
+52,200
+150% +$471K 0.08% 177
2021
Q4
$377K Buy
+34,891
New +$377K 0.04% 262

Other funds holding AMYT

Clear Harbor Asset Management's AMYT Position: Q1 2023 in Review

Clear Harbor Asset Management sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q1 2023, closing a stake of 74,843 shares — an estimated $546K sold.

Clear Harbor Asset Management first reported a position in AMYT in Q4 2021 and held it in 5 quarters. The position peaked at $720K in Q1 2022. 79 funds tracked by Wall St. Rank hold AMYT as of Q1 2023.

  • Clear Harbor Asset Management reported no remaining Amryt Pharma plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Clear Harbor Asset Management sold 74,843 Amryt Pharma plc American Depositary Shares shares in Q1 2023, an estimated $546K.
  • Clear Harbor Asset Management first reported a position in Amryt Pharma plc American Depositary Shares in Q4 2021 and held it in 5 quarters.
  • Clear Harbor Asset Management's Amryt Pharma plc American Depositary Shares position peaked at $720K in Q1 2022.
  • 79 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q1 2023.

Based on Clear Harbor Asset Management's 13F filing for Q1 2023, filed 4 May 2023.